Company Profile

Oakwood Laboratories LLC
Profile last edited on: 11/1/16      CAGE: 4X7C4      UEI:

Business Identifier: Drug delivery systems
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

7670 First Place Suite A
Oakwood, OH 44146
   (440) 359-0000
Location: Single
Congr. District: 11

Public Profile

Oakwood Laboratories is a privately owned specialty pharmaceutical company focused on the design, development and commercial manufacture of sterile injectable sustained release pharmaceuticals. This unique class of products delivers therapeutic levels of drug to patients over days, weeks, months or even years with a single intramuscular or subcutaneous injection. Products of this class have extremely high commercial potential. Oakwood developed and owns a patented microsphere-based drug delivery platform called Chroniject to produce sustained release injectables. This technology employs a continuous aseptic process.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2008 1 NIH $205,271
Project Title: Improved Therapy Of Prostate Cancer
2001 1 NIH $107,000
Project Title: Cyclo(His-Pro) Decreases Voluntary Alcohol Consumption

Key People / Management

  Edward Smith -- Chairman and Chief Executive Officer

  Mark T Smith -- President

  Jeffrey Fehn -- Executive Vice President and Chief Financial Officer

  Bruce K Schrier

  Bagavathikanun C Thanoo -- Vice President of Product Development